PAII · Pyrophyte Acquisition Corp. II
$10.30
+0.01 (+0.10%)
At close · Sep 11
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“In connection with management's evaluation of the Company's ability to continue as a going concern in accordance with FASB ASC Topic 205-40, "Presentation of Financial Statements – Going Concern," the Company's liquidity concerns and the mandatory liquidation within the next 12 months (except the Company extends through shareholders vote) raise substantial doubt about the Company's ability to continue as a going concern for a period of one year from the date the unaudited condensed financial statements are available to be issued.”View the 10-Q filed Aug 14, 2026
Market Cap
$280.85M
Shares
27.27M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$10.30
Open$10.30
Day$10.30–10.30
52W close$9.92–10.30
Avg vol 30d31K
Short int2K · 0.0% float · 1.0d
Short vol30%
DataSep 2025–Sep 2026
Filing10-Q · Aug 14
Up next
filed Aug 14, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$1,136
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
0.0%
Latest settlement · 1.0 days to cover
Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Buy
Momentum
Strong
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very Low
Market backdrop
VIX 15.8 · calm
Equity put/call 0.60
Technical
price trend
50 / 200-day cross
No cross
Price vs 50-day avg
+1%
above
RSI (14)
78
overbought
MACD trend
Positive
52-week position
100%
near high
Momentum
relative strength
1-month return
+1%
trailing
6-month return
+2%
trailing
YTD return
+2%
this year
Relative strength
−16%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Distributing
-7% holders QoQ · +4 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.01% of float · ▼ -6.2% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
50 holders — mid 1-yr range
Squeeze score
34
low risk · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
3%
annualized · 1-yr
Max drawdown
−1%
past year
ATR
0.1%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 50-day avg
+1%
Bullish
RSI (14)
78
Bearish
MACD trend
Positive
Bullish
52-week position
100%
Bullish
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Distributing
-7% holders QoQ · +4 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.01% of float · ▼ -6.2% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
50 holders — mid 1-yr range
Price context
position in its 52-week range
Range low $10
Now $10 · 100%
Range high $10
vs 50-day avg +1%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Shell Companies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
PAII
this stock
Pyrophyte Acquisition Corp. II
|
$280.85M | +2.4% | — | — | 0.0% |
|
CLUS
Cluster Group Holdings Ltd Co
|
$8.00B | — | — | — | — |
|
CCXI
Churchill Capital Corp XI
|
$686.22M | — | — | — | 6.7% |
|
DMII
Drugs Made In America Acquisition II Corp.
|
$647.37M | +2.7% | — | — | 0.2% |
|
EVAC
EQV Ventures Acquisition Corp. II
|
$602.01M | +2.7% | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| PAII | +0.2% | +0.8% | +2.2% | +0.1% | +2.4% |
| SPY | -1.2% | -1.8% | +17.8% | -0.4% | +12.1% |
| vs SPY | +1.3% | +2.5% | -15.7% | +0.5% | -9.7% |
Key facts
CIK
2069238
CUSIP
G7309T102
13F (30d)
40 filings
40 filers
Visit website
Investor relations